|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/42 | |
| C07K 16/32 |
| (11) | Number of the document | 3046583 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14845738.5 |
| Date of filing the European patent application | 2014-09-18 | |
| (97) | Date of publication of the European application | 2016-07-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/056412 |
| Date | 2014-09-18 |
| (87) | Number | WO 2015/042325 |
| Date | 2015-03-26 |
| (30) | Number | Date | Country code |
| 201361879627 P | 2013-09-18 | US |
| (72) |
DE LOS PINOS, Elisabet, US
SCHILLER, John, T., US
KINES, Rhonda, C., US
MACDOUGALL, John, US
|
| (73) |
Aura Biosciences, Inc.,
85 Bolton Street, Cambridge, MA 02140,
US
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, Maryland 20892-7660, US |
| (54) | VIRUS-LIKE PARTICLE CONJUGATES FOR TREATMENT OF TUMORS |
| VIRUS-LIKE PARTICLE CONJUGATES FOR TREATMENT OF TUMORS |